4/A//SEC Filing
Sherman Jeffrey Scott 4/A
Accession 0001077183-24-000169
CIK 0001077183other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:10 PM ET
Size
9.3 KB
Accession
0001077183-24-000169
Insider Transaction Report
Form 4/AAmended
Sherman Jeffrey Scott
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-11+13,005→ 138,667 total - Tax Payment
Common Stock
2024-05-11$14.86/sh−3,167$47,062→ 135,500 total - Exercise/Conversion
Restricted Stock Unit
2024-05-11−13,005→ 26,011 totalExercise: $0.00→ Common Stock (13,005 underlying)
Footnotes (5)
- [F1]Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
- [F2]Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
- [F3]On May 14, 2024, the reporting person filed a Form 4 which inadvertently reported the number of shares of common stock received upon the vesting of certain of his RSUs twice. In fact, as reported in this amendment, the reporting person directly owned 135,500 shares of common stock after the vesting of 13,005 RSUs and reported withholding.
- [F4]On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F5]Once vested, the shares of common stock are not subject to expiration.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001463145
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:10 PM ET
- Size
- 9.3 KB